熊果酸激活低分化鼻咽癌细胞氯通道和减小细胞容积

本文旨在研究熊果酸对低分化鼻咽癌细胞氯通道的激活作用,以及熊果酸对其细胞容积的影响。采用膜片钳技术记录熊果酸激活的鼻咽癌细胞(CNE-2Z)全细胞氯电流,应用离子置换、改变细胞外渗透压、氯通道阻断剂等观察熊果酸诱导的氯电流的特性,活细胞动态图像分析技术测量细胞容积变化。结果显示,等渗条件下可记录到CNE-2Z细胞微弱且稳定的背景氯电流,细胞外灌流熊果酸可浓度依赖性(1～100nmol/L)诱发氯电流的产生,在±80mV电压钳制下,100nmol/L熊果酸激活的氯电流的平均电流密度为(78.92±6.39)pA/pF和(59.86±4.86)pA/pF,该电流具有较明显的外向优势,不表现明显的时间依赖性和电压依赖性失活。该电流翻转电位为(4.83±0.30)mV,较接近Cl平衡电位(0.9mV)。熊果酸激活的氯通道对不同阴离子的通透性为:Cl-=I->Br->葡萄酸根离子。该电流具有容积敏感性,可被细胞外高渗透压显著抑制;氯通道阻断剂他莫昔芬(tamoxifen)、5-硝基-2-(3-苯丙胺)苯甲酸[(5-nitro-2-(3-phenylpro-pylamino)benzoic acid,NPPB]可抑制该电流。细胞外灌流熊果酸1h后,细胞容积减小,氯通道阻断剂NPPB可抑制该容积变化。以上结果提示,熊果酸可以激活低分化鼻咽癌细胞的氯通道,使Cl外流,进而引起细胞容积减小。     

白花蛇舌草化学成分的研究

从茜草科植物白花蛇舌草(Oldenlandia diffusa (Willd)Roxb.)的水提取物中分离得到三个化合物,1,2,3。经理化常数测定及UV,IR,NMR,MS分析以及衍生物制备等方法,鉴定化合物1为熊果酸,化合物2为齐墩果酸,化合物3为4,4′-二羟基-α-古柯间二酸,其中化合物3为首次从天然界分得。     

熊果酸在肿瘤治疗中的研究进展

熊果酸(ursolic acid)是广泛存在于自然界植物中的一种五环三萜类化合物,具有广泛的生物学活性,主要经肝脏代谢。传统临床治疗中熊果酸多用于抗炎、抗病毒、调节免疫功能以及保肝治疗等。近年来的研究表明,在体外和体内实验中,熊果酸能够对不同肿瘤细胞产生杀伤作用,抑制恶性肿瘤组织的生长,具有广谱的抗肿瘤活性。此外,熊果酸联合放化疗能够提高肿瘤细胞对治疗的敏感性,产生辅助增强放化疗疗效的作用,并且在放疗中可保护受照射机体的正常组织,促进免疫机能的恢复。熊果酸的抗肿瘤作用机制与下调促肿瘤生长、侵袭和转移相关基因的水平,增强凋亡基因的表达有关,并且能够通过调节多种细胞信号转导通路,杀灭肿瘤细胞,延缓肿瘤组织生长。同时,熊果酸可影响肿瘤细胞周期的分布,导致细胞的G1/S期阻滞,从而抑制肿瘤细胞的有丝分裂,诱导细胞凋亡。因此,熊果酸是一种极具潜力的天然抗肿瘤药物。本文对熊果酸在肿瘤治疗中的研究结果进行整合,阐述了熊果酸的抗肿瘤分子机制及其疗效,为熊果酸今后在临床中的进一步应用提供指导思路。     

熊果酸对糖尿病小鼠肾病的保护作用及机制研究

目的：观察熊果酸（UA）对四氧嘧啶诱导的糖尿病小鼠肾病的影响,并探讨其作用机制。方法：昆明种小鼠一次性尾静脉注射四氧嘧啶（70mg／kg）,72h后将血糖高于13．9mmol／L者视为糖尿病模型。随机分为对照组、模型组和uA组（35mg/kg,i．g．）,连续给药8周。测定血糖,肾脏脏器系数,肾组织中超氧化物歧化酶（SOD）,丙二醛（MDA）,肿瘤坏死因子-α（TNF-α）及白细胞介素-6（IL-6）;HE染色观察肾组织病理变化。结果：模型组血糖、脏器指数升高;肾组织中SOD活力降低,MDA含量明显升高;TNE-α,IL-6表达增多;病理学显示模型组肾脏细胞萎缩,排列不整齐,可见炎症细胞浸润和间质增生,UA组明显改善上述变化。结论：熊果酸对四氧嘧啶致糖尿病小鼠肾脏损伤有明显的改善作用,其机制可能与降血糖,抗氧化作用和抑制炎症因子TNF-α、IL-6有关。     

桔梗悬浮细胞对莪二酮的生物转化研究

目的:利用植物悬浮细胞体系对莪二酮进行结构改造研究.方法:采用生物转化技术和天然药物化学手段,分离转化产物单体,并利用波谱学手段对转化产物进行结构鉴定,并利用MTT法对转化产物的抗肿瘤活性进行了评价.结果:分离并鉴定了5个转化产物,分别为1β,10α-环氧基莪二酮(2),3α-羟基-莪二酮(3),3β-羟基-莪二酮(4),1α,10β-环氧基-11-羟基莪二酮(5)和2β-羟基-莪二酮(6).结论:桔梗悬浮细胞对于莪二酮具有良好的转化能力,可以利用其作为植物反应器对莪二酮进行结构改造,以获得水溶性更好或活性更佳的衍生物.     

女贞子提取物主要活性组分及其抗丙型肝炎病毒复制活性分析

中药女贞子(Ligustrum lucidum,LL)具有肝保护和抗炎症作用.本研究分析女贞子提取物对丙型肝炎病毒(hepatitis C virus, HCV)复制的影响及其活性成分. 薄层层析法分离女贞子水提取物,获得5个分离组分. Real-time RT-PCR 和Western印迹发现,分离组分1和2 抑制HCV JFH1细胞感染模型中的JFH1病毒复制. 分离组分的高效液相色谱(high-performance liquid chromatography,HPLC)分析表明,熊果酸和齐墩果酸可能是组分1 和 2的抗病毒活性成分. 熊果酸和齐墩果酸抗病毒实验发现,熊果酸和齐墩果酸抑制HCV JFH1的复制,它们的选择指数 (SI) 分别为 6.7 和30.8. 这些研究结果表明,女贞子及其化学成分熊果酸和齐墩果酸具有潜在的丙型肝炎治疗价值.     

厚朴酚与和厚朴酚衍生物的合成、表征及体外抗炎及抗肿瘤活性评价

厚朴酚与和厚朴酚是天然产物中的活性单体,在抗炎和抗肿瘤增殖方面表现出优异的药理活性,但其细胞毒性限制了它们的应用。这促使研究者们对其进行结构修饰,以期降低其细胞毒性且保持甚至提高药理活性。本研究对厚朴酚与和厚朴酚的酚羟基进行修饰,通过引入酯基、酰肼、1,3,4-噁二唑等结构,合成了6个衍生物,其中5个衍生物为首次报道,并通过UV、IR、MS、NMR分析与晶体结构对6个衍生物进行了结构表征和绝对构型的确定。对所得衍生物进行了体外细胞毒性、抗炎和抗肿瘤活性评价。结果显示,所得衍生物对小鼠巨噬细胞(RAW264.7)细胞毒性较原型药物显著降低,可在不同程度上抑制炎症介质NO、IL-1β和TNF-α的产生,可有效抑制人乳腺癌(MCF-7)、人肝癌(HepG2)、人非小细胞肺癌(H1299、A549)的增殖。综上所述,本研究为天然产物的减毒增效衍生化设计提供了一定的参考价值。     

拐芹倍半萜没药烷吉酮的结构修饰及其对H~+/K~+-ATP酶的抑制作用

三峡区域药用植物拐芹的根中富含倍半萜类抗溃疡活性成分没药烷吉酮,为可开发和利用的中草药资源。本文对该化合物进行了提取分离、结构修饰和初步的构效关系研究,从拐芹根茎中提取并分离了没药烷吉酮,通过选择性还原、缩合和加成反应制备了四个没药烷吉酮氨基甲酰腙衍生物。用核磁共振波谱、质谱、红外和元素分析等方法确证了其结构,并测试了其体外对H~+/K~+-ATP酶的抑制活性和细胞毒活性。没药烷吉酮还原衍生物2及4-氯苯基取代的氨基甲酰腙衍生物4d较阳性对照药物奥美拉唑具有更好的体外抗溃疡活性(IC5024μmol/L)。本文探明了没药烷吉酮衍生物的结构对体外H~+/K~+-ATP酶抑制活性的影响,为消化性溃疡的治疗提供了新型倍半萜类候选药物。     

拐芹倍半萜没药烷吉酮的结构修饰及其对H~+/K~+-ATP酶的抑制作用

三峡区域药用植物拐芹的根中富含倍半萜类抗溃疡活性成分没药烷吉酮,为可开发和利用的中草药资源。本文对该化合物进行了提取分离、结构修饰和初步的构效关系研究,从拐芹根茎中提取并分离了没药烷吉酮,通过选择性还原、缩合和加成反应制备了四个没药烷吉酮氨基甲酰腙衍生物。用核磁共振波谱、质谱、红外和元素分析等方法确证了其结构,并测试了其体外对H~+/K~+-ATP酶的抑制活性和细胞毒活性。没药烷吉酮还原衍生物2及4-氯苯基取代的氨基甲酰腙衍生物4d较阳性对照药物奥美拉唑具有更好的体外抗溃疡活性(IC50<24μmol/L)。本文探明了没药烷吉酮衍生物的结构对体外H~+/K~+-ATP酶抑制活性的影响,为消化性溃疡的治疗提供了新型倍半萜类候选药物。     

清香木姜子的化学成分

从清香木姜子（Litsea euosma W．W．Smith）的枝叶中分离得到1个新化合物-α-吡喃酮衍生物（1）以及3个已知化合物：阿魏酸酯衍生物（2）,6-氧-棕榈酰-β-胡萝卜甙（3）和葡萄糖（4）,经波谱学鉴定新化合物α-吡喃酮衍生物的结构为：5-经基-6-甲基-3-（10-十一烯基）-5,6-二氢吡哺-2-酮。     

Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides

Several 8-chloro-7-R1-6-R2-3-R3-imidazo[1,2-b][1,4,2]benzodithiazine 5,5-dioxide derivatives (9-11, 16-19, and 21-24) have been synthesized as potential antitumor or anti-HIV agents. The in vitro antitumor and anti-HIV-1 activities of the compounds were determined in a panel of cell lines. The benzodithiazine-dioxide 10 showed 50% growth inhibitory activity in low micromolar against most cells. It was particularly effective in leukemia, lung, melanoma, ovarian, and renal cancer cells with GI50 values of 1-2 microM. Interestingly, benzodithiazine-dioxide 16 showed remarkable anti-HIV-1 activity with 50% effective concentration EC50 value of 0.94 microM and no significant cytotoxicity at 200.0 microM.     

腺花香茶菜中的三萜化合物

对云南大理产腺花香茶菜（Isodon adenanthus)进行了系统的研究。从中分离得到了包括1个新三萜（1）在内的一系列乌索烷型三萜类化合物,其结构通过现代波谱分析方法确定。活性筛选结果表明,化合物1对肿瘤细胞株K562,A549以及T24具有一定的细胞毒活性。     

Synthesis and Antitumor Evaluation in Vitro of NO‐Donating Ursolic Acid‐Benzylidene Derivatives

Antitumor activity of triterpenoid and its derivatives has attracted great attention recently. Our previous efforts led to the discovery of a series of NO‐donor betulin derivatives with potent antitumor activity. Herein, we prepared eight compounds derived from ursolic acid (UA). All the compounds were evaluated for their in vitro cytotoxicity against four human cancer cell lines (HepG‐2, MCF‐7, HT‐29 and A549). Among the compounds tested, compound 4a was found to be most active against HT‐29 (IC₅₀=4.28 μm ). Further biological assays demonstrated that compound 4a could induce cell cycle arrest at G1 phase and apoptosis in a dose‐dependent manner. In addition, compound 4a was found to upregulate pro‐apoptotic Bax, p53 and downregulate anti‐apoptotic Bcl‐2. All these results suggested that compound 4a is a potential candidate drug for the therapy of colon cancer.     

Effect of nitrogen-containing derivatives of the plant triterpenes betulin and glycyrrhetic acid on the growth of MT-4, MOLT-4, CEM, and Hep G2 tumor cells

Derivatives of the available plant triterpenes glycyrrhetic acid and betulin (betulin succinates and amides of betulonic and 18beta-glycyrrhetic acids containing fragments of long-chain amino acids and a peptide) were synthesized. The inhibitory action of these compounds on the growth of MT-4, MOLT-4, CEM. and Hep G2 tumor cells and their effect on the apoptosis of these cells were studied. It was shown that betulonic acid amides are more effective inhibitors of the tumor cell growth than the corresponding amides of glycyrrhetic acid. It was also found that betulonic acid amides containing fragments of caprylic, pelargonic, and undecanoic acids are more effective inhibitors of tumor cell growth than betulinic acid. The 17-dipeptide derivative of betulonic acid N-{N-[3-oxo-20(29)-lupen-28-oyl]-9-aminononanoyl}-3-amino-3-phenylpropionic acid exhibited the maximum inhibitory activity toward the tumor cells studied. Data on the induction of apoptosis in tumor cells by betulin derivatives at a concentration of 10 microg/ml were obtained by flow cytometry. The amides of betulonic acid proved to be the most effective inducers of apoptosis.     

Effect of nitrogen-containing derivatives of the plant triterpenes betulin and glycyrrhetic acid on the growth of MT-4, MOLT-4, CEM,and Hep G2 tumor cells

Derivatives of the available plant triterpenes glycyrrhetic acid and betulin (betulin succinates and amides of betulonic and 18β-glycyrrhetic acids containing fragments of long-chain amino acids and a peptide) were synthesized. The inhibitory action of these compounds on the growth of MT-4, MOLT-4, CEM, and Hep G2 tumor cells and their effect on the apoptosis of these cells were studied. It was shown that betulonic acid amides are more effective inhibitors of the tumor cell growth than the corresponding amides of glycyrrhetic acid. It was also found that betulonic acid amides containing fragments of caprylic, pelargonic, and undecanoic acids are more effective inhibitors of tumor cell growth than betulinic acid. The 17-dipeptide derivative of betulonic acid N-{N-[3-oxo-20(29)-lupen-28-oyl]-9-aminononanoyl}-3-amino-3-phenylpropionic acid exhibited the maximum inhibitory activity toward the tumor cells studied. Data on the induction of apoptosis in tumor cells by betulin derivatives at a concentration of 10 μg/ml were obtained by flow cytometry. The amides of betulonic acid proved to be the most effective inducers of apoptosis.     

Clinically useful anticancer,antitumor, and antiwrinkle agent,ursolic acid and related derivatives as medicinally important natural product

Medicinal plants are becoming an important research area for novel and bioactive molecules for drug discovery. Novel therapeutic strategies and agents are urgently needed to treat different incurable diseases. Many plant derived active compounds are in human clinical trials. Currently ursolic acid is in human clinical trial for treating cancer, tumor, and skin wrinkles. This review includes the clinical use of ursolic acid in various diseases including anticancer, antitumor, and antiwrinkle chemotherapies, and the isolation and purification of this tritepernoid from various plants to update current knowledge on the rapid analysis of ursolic acid by using analytical methods. In addition, the chemical modifications of ursolic acid to make more effective and water soluble derivatives, previous and current information regarding, its natural and semisynthetic analogs, focusing on its anticancer, cytotoxic, antitumor, antioxidant, anti-inflammatory, anti-HIV, acetyl cholinesterase, α-glucosidase, antimicrobial, and hepatoprotective activities, briefly discussion is attempted here for its research perspectives. This review article contains fourteen medicinally important ursolic acid derivatives and 351 references.     

Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product

Medicinal plants are becoming an important research area for novel and bioactive molecules for drug discovery. Novel therapeutic strategies and agents are urgently needed to treat different incurable diseases. Many plant derived active compounds are in human clinical trials. Currently ursolic acid is in human clinical trial for treating cancer, tumor, and skin wrinkles. This review includes the clinical use of ursolic acid in various diseases including anticancer, antitumor, and antiwrinkle chemotherapies, and the isolation and purification of this tritepernoid from various plants to update current knowledge on the rapid analysis of ursolic acid by using analytical methods. In addition, the chemical modifications of ursolic acid to make more effective and water soluble derivatives, previous and current information regarding, its natural and semisynthetic analogs, focusing on its anticancer, cytotoxic, antitumor, antioxidant, anti-inflammatory, anti-HIV, acetyl cholinesterase, α-glucosidase, antimicrobial, and hepatoprotective activities, briefly discussion is attempted here for its research perspectives. This review article contains fourteen medicinally important ursolic acid derivatives and 351 references.     

Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones

Novel series of 1-(arenesulfonyl)imidazolidin-2-one (3a-i) and 1,3-bis(arenesulfonyl)imidazolidin-2-one (5a-i) have been synthesized and tested for their antitumor activity against 60 tumor cell lines taken from nine different organs. A significant inhibition for cancer cells was observed with series 5a-i compounds compared with the series 3a-i which showed a weak inhibition. Compounds 5a-i showed good inhibitory effect at the lung cancer HOP-92 and renal cancer CAKI-1 and UO-31 cell lines. Compound 5e showed remarkable broad-spectrum antitumor activity.     

A phthalimide derivative that inhibits centrosomal clustering is effective on multiple myeloma

Despite the introduction of newly developed drugs such as lenalidomide and bortezomib, patients with multiple myeloma are still difficult to treat and have a poor prognosis. In order to find novel drugs that are effective for multiple myeloma, we tested the antitumor activity of 29 phthalimide derivatives against several multiple myeloma cell lines. Among these derivatives, 2-(2,6-diisopropylphenyl)-5-amino-1H-isoindole-1,3- dione (TC11) was found to be a potent inhibitor of tumor cell proliferation and an inducer of apoptosis via activation of caspase-3, 8 and 9. This compound also showed in vivo activity against multiple myeloma cell line KMS34 tumor xenografts in ICR/SCID mice. By means of mRNA display selection on a microfluidic chip, the target protein of TC11 was identified as nucleophosmin 1 (NPM). Binding of TC11 and NPM monomer was confirmed by surface plasmon resonance. Immunofluorescence and NPM knockdown studies in HeLa cells suggested that TC11 inhibits centrosomal clustering by inhibiting the centrosomal-regulatory function of NPM, thereby inducing multipolar mitotic cells, which undergo apoptosis. NPM may become a novel target for development of antitumor drugs active against multiple myeloma.     

Ligand-receptor interaction between triterpenoids and the 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) enzyme predicts their toxic effects against tumorigenic r/m HM-SFME-1 cells

The present study deals with in silico prediction and in vitro evaluation of the selective cytotoxic effects of triterpenoids on tumorigenic human c-Ha-ras and mouse c-myc cotransfected highly metastatic serum-free mouse embryo-1 (r/m HM-SFME-1) cells. Ligand fitting of five different triterpenoids to 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2) was analyzed with a molecular modeling method, and glycyrrhetinic acid (GA) was the best-fitted triterpenoid to the ligand binding site in 11βHSD2. Analysis of antiproliferative effects revealed that GA, oleanolic acid, and ursolic acid had selective toxicity against the tumor cells and that GA was the most potent triterpenoid in its selectivity. The toxic activity of the tested triterpenoids against the tumor cells showed good correlations with the partition coefficient (logP) and polar surface area values. Time-lapse microscopy, fluorescence staining, and confocal laser scanning microscopic observation revealed that GA induced morphologic changes typical of apoptosis such as cell shrinkage and blebbing and also disrupted the cytoskeletal proteins. Furthermore, GA exhibited a strong inhibitory effect on 11βHSD2 activity in the tumor cells. Our current results suggest that analysis of the ligand-receptor interaction between triterpenoids and 11βHSD2 can be utilized to predict their antitumor effects and that GA can be used as a possible chemopreventive and therapeutic antitumor agent. To the best of our knowledge, this is the first report on in silico prediction of the toxic effects of triterpenoids on tumor cells by 11βHSD2 inhibition.